Moxifloxacin Hydrochloride Tablet, Film Coated
Product Images NDC 71335-2815

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride (NDC 71335-2815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352815)

This is information about a medication labeled as Moxifloxacin Tablets, USP. Each film-coated tablet contains 400 mg of Moxifloxacin (equivalent to 436.33 mg Moxifloxacin Hydrochloride). The tablets should be stored at 20° to 25°C (68° to 77°F) and protected from excessive humidity. This medication should be kept out of reach of children and is for prescription use only. The pharmaceutical company responsible for packaging the medication is Bryant Ranch Prepack, Inc., and it is manufactured by Aurobindo Pharma Limited. Be sure to dispense a Medication Guide to each patient. More information can be found at the provided web link.*

FDA Label Image

Figure 1 (Moxifloxacin Fig1)

This text appears to relate to dosages for intravenous (i.v.) and oral administrations over time. The graph or chart seems to show a comparison between the two modes of administration at different time points indicated in hours.*

FDA Label Image

Structure (Moxifloxacin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.